Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021 is a research paper published in Antimicrobial Stewardship & Healthcare Epidemiology (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: T32 GM008169
NIGMS NIH HHS
Grant: T32 GM142617
National Institutes of Health
Grant: 5K24AI114444-02
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
National Institutes of Health
Grant: 1P30AI168386-01
Emory/Georgia TB Research Advancement Center (TRAC)
National Institutes of Health
Grant: 1U54CA260563-01
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
National Institutes of Health
Grant: 5K23AI134182-03
Impact of HIV infection on early responses to TB exposure
FWCI
0.19
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals